| Business Type: | Manufacturer, Trading Company | Verified |
|---|---|---|
| Location: | China | Verified |
| Main Products: | ((5-thiazolyl)methyl)-(4-Nitrophenyl)carbonate,(1R,1'R)-2,2'-(3,11-Dioxo-4,10-dioxatridecamethylene)-biS-(1,2,3,4-tetrahydro-6,7-dimethoxy-1-veratrylisoquindline)-dioxalate | Verified |
| Ownership: | Jinlan Pharm-Drugs Technology Co.,Limited | Verified |
| Total Employees: | 200 | Verified |
| Total Annual Revenue: | Above US$100 Million | Verified |
| Year Established: | 2018 | Verified |
| Top 3 Markets: | Southeast Asia: 31.93%, South Asia: 25.05%, Mid East: 14.61% | Verified |
| Certifications (0): |
| Picture | Certification Name | Certified By | Business Scope | Available Date --- Expired Date | Verified |
|---|
| Main Markets | Total Revenue(%) |
|---|---|
| Southeast Asia | 31.93% |
| South Asia | 25.05% |
| Mid East | 14.61% |
